BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 25461979)

  • 1. Endocannabinoid metabolism by cytochrome P450 monooxygenases.
    Zelasko S; Arnold WR; Das A
    Prostaglandins Other Lipid Mediat; 2015; 116-117():112-23. PubMed ID: 25461979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of endocannabinoids.
    Biernacki M; Skrzydlewska E
    Postepy Hig Med Dosw (Online); 2016 Aug; 70(0):830-43. PubMed ID: 27516570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid receptor antagonists and fatty acids alter endocannabinoid system gene expression and COX activity.
    Kim J; Watkins BA
    J Nutr Biochem; 2014 Aug; 25(8):815-23. PubMed ID: 24854955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hind limb suspension and long-chain omega-3 PUFA increase mRNA endocannabinoid system levels in skeletal muscle.
    Hutchins-Wiese HL; Li Y; Hannon K; Watkins BA
    J Nutr Biochem; 2012 Aug; 23(8):986-93. PubMed ID: 22051448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
    Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
    CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the endocannabinoid system in the mechanisms involved in the LPS-induced preterm labor.
    Bariani MV; Domínguez Rubio AP; Cella M; Burdet J; Franchi AM; Aisemberg J
    Reproduction; 2015 Dec; 150(6):463-72. PubMed ID: 26347521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction.
    Hutch CR; Hillard CJ; Jia C; Hegg CC
    Neuroscience; 2015 Aug; 300():539-53. PubMed ID: 26037800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocannabinoids and Their Pharmacological Actions.
    Pertwee RG
    Handb Exp Pharmacol; 2015; 231():1-37. PubMed ID: 26408156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endocannabinoid system.
    Kilaru A; Chapman KD
    Essays Biochem; 2020 Sep; 64(3):485-499. PubMed ID: 32648908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of the Endocannabinoid System in the Central Nervous System.
    Hu SS; Mackie K
    Handb Exp Pharmacol; 2015; 231():59-93. PubMed ID: 26408158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel CB1-ligands maintain homeostasis of the endocannabinoid system in ω3- and ω6-long-chain-PUFA deficiency.
    Hammels I; Binczek E; Schmidt-Soltau I; Jenke B; Thomas A; Vogel M; Thevis M; Filipova D; Papadopoulos S; Stoffel W
    J Lipid Res; 2019 Aug; 60(8):1396-1409. PubMed ID: 31167809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling.
    Dobrosi N; Tóth BI; Nagy G; Dózsa A; Géczy T; Nagy L; Zouboulis CC; Paus R; Kovács L; Bíró T
    FASEB J; 2008 Oct; 22(10):3685-95. PubMed ID: 18596221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut feelings about the endocannabinoid system.
    Di Marzo V; Piscitelli F
    Neurogastroenterol Motil; 2011 May; 23(5):391-8. PubMed ID: 21481098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoid system and drug addiction: new insights from mutant mice approaches.
    Maldonado R; Robledo P; Berrendero F
    Curr Opin Neurobiol; 2013 Aug; 23(4):480-6. PubMed ID: 23490550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibitory action of exo- and endocannabinoids on [³H]GABA release are mediated by both CB₁and CB₂receptors in the mouse hippocampus.
    Andó RD; Bíró J; Csölle C; Ledent C; Sperlágh B
    Neurochem Int; 2012 Jan; 60(2):145-52. PubMed ID: 22133429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Manipulation of the Endocannabinoid System.
    Zimmer A
    Handb Exp Pharmacol; 2015; 231():129-83. PubMed ID: 26408160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic changes to the endocannabinoid system in models of chronic pain.
    Rani Sagar D; Burston JJ; Woodhams SG; Chapman V
    Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3300-11. PubMed ID: 23108548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel endogenous cytochrome p450 arachidonate metabolites with high affinity for cannabinoid receptors.
    Chen JK; Chen J; Imig JD; Wei S; Hachey DL; Guthi JS; Falck JR; Capdevila JH; Harris RC
    J Biol Chem; 2008 Sep; 283(36):24514-24. PubMed ID: 18606824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in the endocannabinoid system in the rat valproic acid model of autism.
    Kerr DM; Downey L; Conboy M; Finn DP; Roche M
    Behav Brain Res; 2013 Jul; 249():124-32. PubMed ID: 23643692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide.
    Loría F; Petrosino S; Mestre L; Spagnolo A; Correa F; Hernangómez M; Guaza C; Di Marzo V; Docagne F
    Eur J Neurosci; 2008 Aug; 28(4):633-41. PubMed ID: 18657182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.